Updated Jul 16, 2026
Berg Edward B is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Edward B. Berg serves as the Senior Vice President and General Counsel at Vaxart, Inc., a biotechnology company focused on developing oral vaccines. His legal expertise and leadership in the company contribute to its strategic direction and compliance with regulatory requirements.
| Role | SVP, General Counsel |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-26 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 36.4K | $0.69 | $25K |
| 2026-03-20 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 8.1K | $0.63 | $5K |
| 2026-03-18 | VXRT | Vaxart, Inc. | A — Grant or award | 115.0K | $0.00 | |
| 2026-02-05 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 9.3K | $0.61 | $6K |
Edward B. Berg serves as the Senior Vice President and General Counsel at Vaxart, Inc., a biotechnology company focused on developing oral vaccines. His legal expertise and leadership in the company contribute to its strategic direction and compliance with regulatory requirements.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Berg Edward B profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.